NCT01626846

Brief Summary

The study will seek to determine whether there is a corresponding deficit in school performance for teenagers with NF1. Secondly, the study seeks to explore the issue of self-esteem in teenagers with NF1.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2012

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2012

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

June 21, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 25, 2012

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2012

Completed
Last Updated

June 25, 2012

Status Verified

June 1, 2012

First QC Date

June 21, 2012

Last Update Submit

June 22, 2012

Conditions

Keywords

Neurofibromatosis

Outcome Measures

Primary Outcomes (1)

  • Evidence of effect on self-esteem evidenced by self-esteem scores

    4 months

Study Arms (1)

NF1 teenagers

Eligibility Criteria

Age14 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Teenagers aged 14-17 years with NF1

You may qualify if:

  • Clinical diagnosis of Neurofibromatosis Type 1

You may not qualify if:

  • Neurofibromatosis Type 2
  • Schwannomatosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

John Jay High School

Cross River, New York, 10518, United States

RECRUITING

MeSH Terms

Conditions

Neurofibromatosis 1Neurofibromatoses

Condition Hierarchy (Ancestors)

NeurofibromaNerve Sheath NeoplasmsNeoplasms, Nerve TissueNeoplasms by Histologic TypeNeoplasmsNeoplastic Syndromes, HereditaryNeurocutaneous SyndromesNervous System DiseasesHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesPeripheral Nervous System DiseasesNeuromuscular DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Eileen Karlik, PhD

    Westchester Community College

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 21, 2012

First Posted

June 25, 2012

Study Start

June 1, 2012

Study Completion

September 1, 2012

Last Updated

June 25, 2012

Record last verified: 2012-06

Locations